Rectal cancer: Assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 1, 2013, Pages 119-126

  Oberholzer, Katja ^a   Menig, Matthias ^a   Pohlmann, Andreas ^b   Junginger, Theodor ^a   Heintz, Achim ^c   Kreft, Andreas ^a   Hansen, Torsten ^a   Schneider, Astrid ^a   Lollert, André ^a   Schmidberger, Heinz ^a   Christoph, Düber ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c St Hildegardis Krankenhaus   (Germany)

Author keywords

chemoradiation; DCE MRI; mucinous carcinoma; pathologic response; pharmacokinetic model; rectal cancer

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COLLOID CARCINOMA; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM ANTERIOR RESECTION; RECTUM CARCINOMA;

CHEMORADIATION; DCE-MRI; MUCINOUS CARCINOMA; PATHOLOGIC RESPONSE; PHARMACOKINETIC MODEL; RECTAL CANCER;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CHEMORADIOTHERAPY, ADJUVANT; CONTRAST MEDIA; FEMALE; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PREVALENCE; PROGNOSIS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84880100291     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23952     Document Type: Article

References (33)

1. Valentini V, Coco C, Picciocchi A, et al. Does downstaging predict improvement outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002; 54: 664-674.
2. Smith FM, Reynolds JV, Miller N, et al. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Sur Oncol 2006; 32: 55-64.
3. Figueiras RG, Goh V, Padhani AR, et al. The role of functional imaging in colorectal cancer. Am J Roentgenol 2010; 195: 54-66.
4. Hamilton SR, Aalton LA,. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the digestive system. Lyon, France: IARC Press; 2000. p 105-120.
5. Symonds DA, Vickery AL,. Mucinous carcinoma of the colon and rectum. Cancer 1976; 37: 1891-1900.
6. Shin US, Yu CS, Kim HJ, et al. Musinous rectal cancer: effectiveness of preoperative chemotherapy and prognosis. Ann Surg Oncol 2011; 18: 2232-2239.
7. Sengul N, Wexner SD, Woodhouse S, et al. Effects of radiotherapy on different histopathological types of rectal carcinoma. Colorectal Dis 2006; 8: 283-288.
8. Negri FV, Wotherspoon A, Cunningham D, Norman AR, Chong G, Ross PJ,. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol 2005; 16: 1305-1310.
9. Catalano V, Loupakis F, Graziano F, et al. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer 2009; 100: 881-887.
10. Grillo-Ruggieri F, Mantello G, Berardi R, et al. Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. Dis Colon Rectum 2007; 50: 1594-1603.
11. Nozoe T, Anai H, Nasu S, Sugimachi K,. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 2000; 75: 103-107.
12. Secco GB, Fardelli R, Campora E, et al. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology 1994; 51: 30-34.
13. Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr, Ray JE,. Mucinous carcinoma-just another colon cancer? Dis Colon Rectum 1993; 36: 49-54.
14. Kim MJ, Park JS, Park SI, et al. Accuracy in differentiation of mucinous and nonmucinous rectal carcinoma on MR imaging. J Comput Assist Tomogr 2003; 27: 48-55.
15. Sobin LH, Wittekind C, (eds.). TNM classification of malignant tumors, 6th ed. New York: John Wiley & Sons, 2007.
16. Quirke P, Durdey P, Dixon MF, Williams NS,. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2: 996-999.
17. Oberholzer K, Pohlmann A, Schreiber W, et al. Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging 2008; 27: 1296-1301.
18. Hoffmann U, Brix G, Knopp MV, et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995; 33: 506-514.
19. Nagtegaal I, Gaspar C, Marijnen C, Van De Velde C, Fodde R, Van Krieken H,. Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour. J Pathol 2004; 204: 183-192.
20. Vliegen RF, Beets GL, Lammering G, et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 2008; 246: 454-462.
21. Griebel J, Mayr NA, de Vries A, et al. Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging 1997; 7: 111-119.
22. Wendum D, Boelle P-Y, Rigau V, Sebbagh N, et al. Mucinous colon carcinoma with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression. Virchows Arch 2003; 442: 111-117.
23. Endrich B, Vaupel P,. The role of microcirculation in the treatment of malignant tumours: facts and fiction. In:, Molls M, Vaupel P, editors. Blood perfusion and microenvironment of human tumors. Berlin: Springer; 1998. p 19-39.
24. Thomlinson RH, Gray LH,. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955; 9: 539-549.
25. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993; 26: 45-50.
26. George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001; 88: 1628-1636.
27. Kremser C, Trieb T, Rudisch A, et al. Dynamic T1 mapping predicts outcome of chemoradiation therapy in primary rectal cancer: sequence implementation and data analysis. J Magn Reson Imaging 2007; 26: 662-671.
28. de Lussanet QG, Backes WH, Griffioen AW, et al. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1309-1315.
29. Evelhoch JL,. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999; 10: 254-259.
30. Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2009; 254: 170-178.
31. Phadani AR, Liu G, Koh DM, et al. Diffusion-weighted imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-125.
32. Hayano K, Shuto K, Koda K, et al. Quantitative measurement of blood flow using perfusion CT for assessing clinicpathologic features and prognosis in patients with rectal cancer. Dis colon Rectum 2009; 52: 1624-1629.
33. Capirci C, Rampin L, Erba PA, et al. Sequential FDG-PET / CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemoradiation therapy. Eur J Nucl Med Mol Imaging 2007; 34: 1583-1593.